Tyrosine Kinase Inhibitors Ameliorate Autoimmune Encephalomyelitis in a Mouse Model of Multiple Sclerosis

Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis

(2011) Brian C. Healy et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation

(2010) K. P. A. MacDonald et al.   BLOOD

Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats

(2010) I. HUITINGA et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Meningeal Mast Cells Affect Early T Cell Central Nervous System Infiltration and Blood-Brain Barrier Integrity through TNF: A Role for Neutrophil Recruitment?

(2010) B. A. Sayed et al.   JOURNAL OF IMMUNOLOGY

c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis

(2010) Ricardo T Paniagua et al.   ARTHRITIS RESEARCH & THERAPY

Transcriptional effects of Colony-stimulating factor-1 in mouse macrophages

(2009) Carol El Chartouni et al.   IMMUNOBIOLOGY

Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role

(2009) Roland Liblau   JOURNAL OF THE NEUROLOGICAL SCIENCES

Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor

(2009) H. Huynh et al.   MOLECULAR CANCER THERAPEUTICS

Imatinib is a substrate for various multidrug resistance proteins

(2009) K. Czyzewski et al.   NEOPLASMA

Inhibition of choroidal neovascularisation in mice by systemic administration of the multikinase inhibitor, sorafenib

(2008) E J Chung et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis

(2008) Chris J. Hedegaard et al.   IMMUNOLOGY

Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma

(2008) Francesca Valcamonico et al.   JOURNAL OF NEURO-ONCOLOGY

The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis

(2008) Yasunori Uemura et al.   JOURNAL OF NEUROIMMUNOLOGY

Effects of the cFMS Kinase Inhibitor 5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in Normal and Arthritic Rats

(2008) J. G. Conway et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

(2008) Scott M. Wilhelm et al.   MOLECULAR CANCER THERAPEUTICS

Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice

(2008) C. Louvet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Up-regulation of platelet-derived growth factor by peripheral-blood leukocytes during experimental allergic encephalomyelitis

(2007) Niklas K. U. Koehler et al.   JOURNAL OF NEUROSCIENCE RESEARCH